Acyclovir or Aβ42 peptides attenuate HSV-1-induced miRNA-146a levels in human primary brain cells
Acyclovir or Aβ42 peptides attenuate HSV-1-induced miRNA-146a levels in human primary brain cells
复制标题
DOI:
10.1097/wnr.0b013e32833da51a
复制
发表时间:
2010-10-06
期刊:
影响因子:
1.7
通讯作者:
Hill, James M.
中科院分区:
文献类型:
--
作者:
Lukiw, Walter J.;Cui, Jian Guo;Hill, James M.
Human brains harbor herpes simplex virus type-1 (HSV-1) DNA, which normally remains quiescent throughout many decades of life. HSV-1 is associated with viral encephalopathy and with the amyloid beta 42 (A beta 42) peptide-enriched lesions that characterize Alzheimer's disease neuropathology. Here we report that infection of human neuronal-glial cells in primary co-culture with HSV-1 induces an irregular hypertrophy of human neuronal-glial cell bodies, an induction of HSV-1 DNA polymerase, and an up-regulation of micro-RNA-146a associated with altered innate-immune responses. Presence of the antiviral acyclovir or soluble A beta 42 peptide significantly attenuated these neuropathological responses. The inhibitory effects of A beta 42 peptide were also observed in an HSV-1-infected CV-1 cell-based viral plaque assay. The results suggest that soluble A beta 42 peptide can invoke non-pathological and anti-viral effects through inactivation of an HSV-1 challenge to human brain cells by simple viral sequestration, viral destruction, or by complex neurogenetic mechanisms. NeuroReport 21:922-927 (C) 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins.